TEM ,3-lactamase variants with the amino acid substitutions R164S, E104K, G238S, and E240K (ABL numbering) display increased activity toward extended-spectrum cephalosporins. The T265M substitution is frequently found to be associated with the above substitutions in extended-spectrum f3-lactamases. However, the residue is located away from the active site in the three-dimensional structure and has been assumed to have no elect on catalysis. To examine the eflect of the substitution on the structure and function of TEM P-lactamase we constructed the following mutants: G238S, T265M, T265M:G238S, and T265M:G238S:E240K. Each enzyme was purified to homogeneity and the kinetic parameters k<,p Km and k.aJKm were determined for cefotaxime, ceftazidime, cephaloridine, and ampicillin. The results indicate that the T265M mutation has little effect on hydrolysis. In addition, we used immunoblotting to show that the substitution has little or no effect on the in vivo steady-state levels of ,3-lactamase.
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TEM P-lactamases are the most common plasmid-mediated ,-lactamases (12) . TEM-1 13-lactamase is considered a broadspectrum P-lactamase because it can hydrolyze both penicillins and cephalosporins (3) . However, it cannot efficiently hydrolyze extended-spectrum cephalosporins such as ceftazidime and cefotaxime. Derivatives of TEM 3-lactamase that are able to hydrolyze extended-spectrum cephalosporins have been identified (11, 19, 20) . These enzymes contain from one to three amino acid substitutions in the active site of the enzymes and have been termed extended-spectrum ,-lactamases (4, 7). The active-site substitutions include E104K, R164S, G238S, and E240K (ABL numbering [1] ). Other amino acid substitutions are often found to be associated with the active-site substitutions. For example, the T265M substitution has been identified in TEM-4, TEM-9, TEM-13, and TEM-14 (7, 11) . The T265M substitution is located distant from the active site in the three-dimensional structure of the enzyme and thus is unlikely to exert a direct effect on substrate specificity (8 coli by the alkaline lysis procedure (18) .
Site-directed mutagenesis. The T265M mutation was constructed by oligonucleotide-directed mutagenesis by the method of Kunkel et al. (9) . In the following oligonucleotide, the underlined A residue results in the conversion of codon 265 from ACG-Thr to ATG-Met: 5'-GACICCCCGTCATG TAGATAAC-3'.
The G238S and G238S:E240K mutants were constructed by cassette mutagenesis by using the plasmid containing the L238-241 excision linker insert (16) . Digestion of this plasmid with the restriction endonuclease BspMl created a deletion in the blaTEM-l gene with the sticky ends shown below. The G238S:T265M and G238S:E240K:T265M mutants were constructed by introducing the T265M mutation into the already constructed G238S and G238S:E240K mutants by site-directed mutagenesis (9) .
Antibiotic susceptibilities. MICs were determined by broth microdilution by the reference procedure of the National Committee for Clinical Laboratory Standards (13). Briefly, twofold dilutions of each antibiotic were made in cationsupplemented Mueller-Hinton broth. The ranges of antibiotic concentrations tested for ampicillin were 0.031 to 8192 ,ug/ml, those for cephaloridine were 0.062 to 640 ,ug/ml, those for cefotaxime were 0.25 to 64 ,Ig/ml, and those for ceftazidime were 0.031 to 64 ,ug/ml. The inoculum was prepared from overnight cultures grown on tryptic soy agar supplemented with 5% sheep erythrocytes. The final concentration of inoculum in each well was 5 x 105 CFU/ml. Microtiter trays were incubated at 37°C for 18 to 24 h. The trays were examined visually, and the lowest concentration of antimicrobial agent that inhibited visual growth was recorded as the MIC.
Immunoblots of ,-lactamases. Steady-state levels of ,-lactamase were examined by immunoblotting exactly as described previously (17) .
,-lactamase purification. TEM-1 1-lactamase and the mutant ,-lactamases were purified to .90% homogeneity. Cultures containing the wild-type and mutant ,B-lactamases were grown overnight at 37°C in 10 ml of Luria-Bertani (LB) broth supplemented with 12.5 jig of chloramphenicol per ml to select for the presence of the plasmid. A total of 2 ml of the overnight cultures was then used to inoculate 2.5 liters of LB plus 12.5 ,ug of chloramphenicol per ml, and the cultures were grown at 37°C for 6 h so that the culture was in the late log phase.
3-lactamase and other periplasmic proteins were isolated by osmotic shock (15) . The wild-type and mutant enzymes were purified by using an anti-,-lactamase antibody affinity column. The affinity matrix was prepared by coupling anti-,B-lactamase antibody to protein A beads as described by Harlow and Lane (6) . For this procedure, the periplasmic extract was bound to the affinity beads in lx phosphate-buffered saline (PBS) overnight at 4°C with gentle agitation. The beads were then put in a column and washed with several bed volumes of 1 x PBS. P-lactamase was eluted from the column with 100 mM sodium acetate (pH 4.0)-500 mM NaCl. The fractions were neutralized to pH 7 with 2 M Tris (pH 9). The purity of the preparation was evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10) (see Fig. 1 ).
Enzyme kinetics. The kinetics of TEM-1 3-lactamase and the mutant derivatives were determined with ampicillin, cephaloridine, cefotaxime, and ceftazidime. The following extinction coefficients were used: ampicillin, 235 Table 1 were purified and the kinetic parameters for ampicillin, cephaloridine, ceftazidime, and cefotaxime hydrolysis were determined. The level of purity of the enzyme preparations was evaluated by SDS-PAGE to be .90% for each of the enzymes (Fig. 1) .
The results of the kinetics experiments are shown in Tables  2 through 5 . It is apparent from these data that the T265M mutation alone has no significant effect on either kcat or Km for any of the substrates tested. Similarly, the addition of the T265M mutation to the extended-spectrum G238S and G238S: E240K ,-lactamases does not significantly affect the kinetic parameters of these enzymes for any of the substrates tested (Tables 2 through 5 ). A possible exception is the effect of the T265M mutation on the G238S and G238S:E240K enzymes in which a two-to threefold decrease in ceftazidime hydrolysis was observed (Table 4) . A detailed description of the kinetic effects of the G238S and G238S:E240K amino acid substitutions on 1-lactam catalysis has been described elsewhere (22) .
The data are included here for comparison with those for the T265M mutant derivatives.
Steady-state I-lactamase levels. Since it is possible that the T265M mutation may exert an effect on the expression levels of 3-lactamase rather than on catalytic efficiency, the in vivo expression levels of wild-type TEM-1 ,B-lactamase and each of the mutants was determined by immunoblotting (Fig. 2) . Total protein from the E. coli strain that produced the mutant 3-lactamases was screened with anti-TEM-1 3-lactamase polyclonal antibodies. The results indicate that the levels of expression of the wild-type, T265M, and G238S enzymes were similar. However, when the T265M mutation was combined with the G238S and G238S:E240K extended-spectrum enzymes there appeared to be small reductions in the expression levels. Thus, rather than providing a stabilizing effect, the T265M mutation may actually destabilize the extended-spectrum enzymes to a small extent.
DISCUSSION
The results of the present study indicate that the T265M substitution has little measurable effect on either the wild-type or the G238S and G238S:E240K extended-spectrum enzymes. A possible exception is the effect of the T265M substitution on the G238S and G238S:E240K enzymes, in which it appears to decrease ceftazidime hydrolysis two-to threefold. This result is consistent with previous observations that the TEM-9 1-lacta- (14, 21) . Since the enzymes differ only in the T265M substitution being present in the TEM-9 enzyme but not in the TEM-26 enzyme, this observation suggests that the T265M substitution results in decreased ceftazidime hydrolysis when it is present in combination with other extended-spectrum mutations (14, 21) .
An interesting question is why, if the T265M substitution confers no selective advantage, has it been found in extendedspectrum ,-lactamases? One explanation is that the blaTEM gene encoding the T265M mutation is a neutral allele that arose by genetic drift. If the mutation is neutral, the fact that it is found in association with extended-spectrum ,B-lactamases suggests that the mutation is prevalent among bacteria containing a blaTEM gene. An alternate explanation is that the T265M mutation may provide some selective advantage that we were not able to measure in the present study. This possibility is very difficult to rule out since we do not know how small an effect constitutes a selective advantage. A third possibility is based on the observation that multiple TEM P-lactamase variants can exist within the same bacterial strain (11) . If high rates of recombination between blaTEM genes occurred in these strains, it is feasible that the T265M mutation could become associated with extended-spectrum mutations in blaTEM genes even in the absence of selection.
